Aliquots Archive — Page 67 of 83
-
October 24, 2013
Shining a light on night blindness
Vanderbilt researchers are studying how mutations in the receptor for light, rhodopsin, cause light blindness. -
October 16, 2013
Relaxin combats insulin resistance
The hormone relaxin may offer a novel approach for treating diet-induced insulin resistance. -
October 14, 2013
Magnesium impacts vitamin D status
Magnesium and vitamin D appear to work together to reduce risk of death from cardiovascular disease and colorectal cancer. -
October 11, 2013
New target for stopping inflammation
Importin alpha 5, a member of a family of proteins that “shuttle” other proteins into the nucleus, is a potential new target for drugs to treat inflammatory diseases. -
October 10, 2013
Probing mutant EGF receptor regulation
Understanding the regulation of mutant EGF receptors commonly found in lung cancers could lead to new targeted therapies. -
October 2, 2013
Early cell death in MS
Death of oligodendrocytes, the cells that make myelin, appears to be an early event in the development of multiple sclerosis. -
September 30, 2013
Gene interactions and cavities
Vanderbilt researchers used existing genome-wide association study datasets to identify gene interactions that contribute to tooth decay.